FDA.reportPublic FDA data

Application 214827

Type
ANDA
Sponsor
MSN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL25MGNoNo
002CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL50MGNoNo
003CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL100MGNoNo
004CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDETABLET;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
70518-3510Chlorpromazine HydrochlorideChlorpromazine HydrochlorideREMEDYREPACK INC.ANDACurrent
70518-3510Chlorpromazine HydrochlorideChlorpromazine HydrochlorideREMEDYREPACK INC.ANDACurrent
70518-3549Chlorpromazine HydrochlorideChlorpromazine HydrochlorideREMEDYREPACK INC.ANDACurrent
70518-3584Chlorpromazine HydrochlorideChlorpromazine HydrochlorideREMEDYREPACK INC.ANDACurrent
72205-104Chlorpromazine HydrochlorideChlorpromazine HydrochlorideNovadoz Pharmaceuticals LLCANDACurrent
72205-105Chlorpromazine HydrochlorideChlorpromazine HydrochlorideNovadoz Pharmaceuticals LLCANDACurrent
72205-106Chlorpromazine HydrochlorideChlorpromazine HydrochlorideNovadoz Pharmaceuticals LLCANDACurrent
72205-107Chlorpromazine HydrochlorideChlorpromazine HydrochlorideNovadoz Pharmaceuticals LLCANDACurrent